Celgene: The Bear Case From A Bull

I haven't been bashful in explaining how I feel about Celgene Corporation (NASDAQ:CELG) stock. Earlier this year, I wrote an article asking if Celgene was simply the best biotech stock on the planet. (The answer was yes.) More recently, I wrote about the one stock I'd buy right now -- and it was Celgene.

So when the opportunity arose to write about the bear case from a bull on Celgene, I clearly fit the description of a bull.

Back to news